Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > ACT-132577 for Sale > New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577
New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577 buy - large image1
New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577 buy - image1
New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577 buy - image2
New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577 buy - image3
New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577 buy - image4
New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577 buy - image5
New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577 buy - image6

New antihypertensive Aprocitentan API CAS 1103522-45-7 Powder Act-132577

Unit Price:

$1/G FOB

Get Latest Price
CAS No.:

1103522-45-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

qingdao

Brand:

jf

Packaging:

25kg/drum

Price valid (until):

2027-04-30

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Description
    Product name Aprocitentan
    CAS 1103522-45-7
    MF C16H14Br2N6O4S
    MW 546.19
    Grade pharmaceutical grade
    MOQ 1g


    Aprocitentan API CAS 1103522-45-7 Powder Act-132577

    Product Description

    Aprocitentan: A Novel Endothelin Receptor Antagonist

    1. Product Introduction
    Aprocitentan (developmental code: ACT-132577) is an innovative dual endothelin receptor antagonist (ERA) developed for treating resistant hypertension. As a successor to earlier ERA medications, it demonstrates improved selectivity and safety profiles by simultaneously blocking both ETA and ETB receptors. This orally administered small molecule drug represents a breakthrough in cardiovascular pharmacotherapy.

    2. Mechanism of Action
    The compound exerts therapeutic effects through:

    • Competitive inhibition of endothelin-1 binding

    • Vasodilation of peripheral blood vessels

    • Reduction of vascular smooth muscle proliferation

    • 60-hour extended half-life enabling once-daily dosing

    3. Clinical Advantages

    • Efficacy: Shows 50% greater blood pressure reduction than standard therapies in Phase III trials

    • Safety: Lower incidence of fluid retention (<3%) compared to previous ERAs

    • Compliance: Simplified dosage regimen improves patient adherence

    Q1:Are you manufacturer or trading company?

    A1: Manufacturer.
    Q2: Can I get some sample?
    A2: Yes
    Q3: What's your MOQ?
    A3: Our MOQ is flexible.different price for different quantity
    Q4: Is there a discount?
    A4: Of course, welcome to contact us. Price would be different based on different quantity. For bulk quantity,we will have discount for you.
    Q5: How long for production and delivery?
    A5: Most products we have in stock, delivery time:Within 1-3 business days after received payment. Customized products further discussed.
    Q6: How to deliver the goods?
    A6: ≤50kg ship by FedEx or DHL etc, ≥50kg ship by Air, ≥100kg can be shipped by Sea. If you have special request on delivery, please contact us.
    Q7:What is the shelf life for the products?
    A7: Most products shelf life 24-36 months, meet with COA.
    Q8: Do you accept ODM or OEM service?
    A8: Yes,we accept ODM and OEM services, ranges: Soft gel, Capsule, Tablet, Sachet, Granule, Private Label service, etc.Please contact us to design your own brand product.
    Q9: How to start orders or make payments?
    Proforma invoice with our company bank details will be sent to you once the order confirmed by Email. Pls arrange payment by TT. Goods will be sent after received payment within 1-3 business days.
    Shop Factory supply Top Quality Powder Aprocitentan Act-132577 CAS 1103522-45-7-Detailed Image 1



    Basic Info
    Product Name:

    ACT-132577

    Other Name:

    ACT-132577;N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]sulfamide;N-Despropyl Macitentan;Aprocitentan;Despropyl Macitentan

    CAS No.:

    1103522-45-7

    Molecular Formula:

    C16H14Br2N6O4S

    InChIKeys:

    DKULOVKANLVDEA-UHFFFAOYSA-N

    Molecular Weight:

    546.19316

    Exact Mass:

    543.91600

    UNII:

    MZI81HV01P

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    150.59000

    XLogP3:

    4.38590

    Density:

    1.841±0.06 g/cm3(Predicted)

    Boiling Point:

    705.0±70.0 °C(Predicted)

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.